Clinical cases of Candida auris jumped more than 50% from 2022 to 2023, according to state data reported to the CDC.

Candida auris, a drug-resistant fungal pathogen, poses a significant threat to healthcare settings, particularly in the New York-New Jersey area, which accounts for nearly 20% of U.S. cases.

The objective of this study was to use a new latex agglutination test to determine the prevalence of Candida albicans and Trichomonas vaginalis in a sample of immunocompetent pregnant women ...

There have been 587 cases reported in the US, according to theCDC, most of them in New York, New Jersey and Illinois. A mysterious and dangerous fungal infection called Candida auris has emerged ...

In 2019, state health officials released the first-ever list of hospitals and nursing homes in New York that treated patients harboring Candida auris, the deadly drug-resistant fungus. That list ...

They called it Candida auris, with auris being the Latin word ... Second, under strong selective pressure, the prevalence of ...